B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia and lymphoma.

---

B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia, lymphoma and rheumatoid arthritis. 3D rendering based on protein data bank entry 2osl. Atoms are represented as spheres with conventional color coding.

---

Size: 4096px × 4096px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: -cell, -lymphocyte, 20, 3d, acid, amino, antibody, antigen, arthritis, atoms, autoimmune, cancer, cd, cd20, cluster, differentiation, disease, epitope, fab, health, histology, illustration, immunohistochemistry, leukemia, lymphocyte, lymphoma, model, molecular, molecule, monoclonal, ms4a1, pdb_2osl, pemphigus, peptide, polymer, polypeptide, protein, purpura, rendering, rheumatoid, rituximab, science, scientific, structure, surface, thrombocytopenic, vulgaris